Avid Bioservices (CDMO) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CDMO Avid Bioservices

Watchlist

12.300
-0.030-0.24%

Close Dec 20 16:00 ET

12.270
-0.030-0.24%

Post 20:01 ET

786.75MMarket Cap-5.10P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Avid Bioservices, Inc. Proposes Transaction With GHO Capital Partners and Ampersand Capital, Encouraging Stockholder Support
Quiver QuantitativeDec 18 16:41 ET
Express News | Avid Bioservices Inc: Special Meeting to Vote on Transaction Scheduled for Jan 30, 2025
ReutersDec 18 16:36 ET
Express News | Avid Bioservices Recommends Stockholders Vote for Value Maximizing Transaction
ReutersDec 18 16:35 ET
Avid Bioservices Recommends Stockholders Vote FOR Value Maximizing Transaction
GlobeNewswireDec 18 16:35 ET
Stephens Maintains Avid Bioservices(CDMO.US) With Hold Rating, Maintains Target Price $12.5
Moomoo NewsDec 11 11:32 ET · Ratings
Craig-Hallum Maintains Avid Bioservices(CDMO.US) With Hold Rating
Moomoo NewsDec 11 09:33 ET · Ratings

Comments

MARKET-TEST-DUMMY

Jul 4 05:44

Hmm

$Avid Bioservices (CDMO.US)$

Moomoo AI

Feb 8 04:32

Investors' belief in Societal CDMO's lackluster revenue performance not improving may be causing its low P/S ratio. The company's inferior revenue outlook compared to the industry average contributes to this. A significant change in fortune is needed to justify a higher P/S.

Societal CDMO, Inc.'s (NASDAQ:SCTL) Shares Bounce 29% But Its Business Still Trails The Industry

Moomoo AI

Jan 26 05:03

The company's high debt and lack of profitability strain its balance sheet. Negative free cash flow adds risk, but its US$417.4m market cap could potentially allow capital raising to strengthen the balance sheet.

We Think Avid Bioservices (NASDAQ:CDMO) Has A Fair Chunk Of Debt

Moomoo AI

Dec 18, 2023 11:16

Investors' belief in Avid Bioservices' stagnant revenue performance and future growth lagging behind the industry has led to its low P/S. The underwhelming revenue outlook and shareholders' pessimism impact the P/S negatively.

Avid Bioservices, Inc.'s (NASDAQ:CDMO) Revenues Are Not Doing Enough For Some Investors

Moomoo AI

Nov 10, 2023 04:56

Despite good revenue growth, the market expected more, as seen in the share price drop. This could hint at delayed revenue growth. The recent sell-off might be an investment chance considering the signs of a continued growth trend.

Further Weakness as Avid Bioservices (NASDAQ:CDMO) Drops 19% This Week, Taking One-year Losses to 66%

Heat List

Overall

No Data